You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. IGF::OT::IGF RELAPSE PREVENTION MOTION AND VOICE VIDEO GAME; POP: 9/2/2014-9/1/2016; N44DA-14-4419 SBIR Phase II (Topic 150) Modification to Remove IT Risk Assessment requirements.

    SBC: MEDIA REZ LLC            Topic: NIDA

    Examining the effects of Motion and Voice Video Game on Relapse prevention in drug addicted youth. PUBLIC HEALTH RELEVANCE

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  2. Developing and Scaling an interactive text messaging tool to help pregnantsmoker

    SBC: Voxiva, Inc            Topic: NIDA

    DESCRIPTION (provided by applicant): There is no more important target audience for smoking cessation efforts than pregnant women. The goal of this Fast Track project is to establish the scientific and technical feasibility of using an interactive text- and web-based application to support smoking cessation among pregnant women. This project aims to develop the first-ever text message based smokin ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  3. Enhancement of Tumor-Targeted Transgene Expression

    SBC: SYNERGENE THERAPEUTICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): In this application, the long-term goal is the development of an effective tumor-targeting lipoplex for systemic treatment of pancreatic cancer (PanCa), which has one of the worst prognosis of all human malignancies. O

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  4. Transportable Chlorine Dioxide Sterilization System

    SBC: PARE TECHNOLOGIES            Topic: N/A

    DESCRIPTION (provided by applicant): Medical infections remain a major cause of morbidity and mortality in the United States. The proposed studies have a primary goal to develop a transportable sterilization cabinet for use in patient care facilitie

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  5. Akt Inhibitors to Treat Ewing's Sarcoma

    SBC: Acenta Discovery, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): Novel drugs that improve overall survival with decreased morbidity are critical in the war on cancer. Acenta Discovery Inc. has partnered with the Toretsky Lab of the Lombardi Cancer Center to create and preclinicall

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  6. Caspase Inhibitor for Neuroprotection

    SBC: Acenta Discovery, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): An important role for apoptosis has been established in various pathological processes, particularly in nervous tissues. Apoptosis essentially contributes to neuronal loss during normal development, after acute neurona

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  7. Flavocoxid: A Medical Food Therapy for Osteoarthritis

    SBC: PRIMUS PHARMACEUTICAL            Topic: N/A

    DESCRIPTION (provided by applicant): Osteoarthritis is a leading chronic disease in older adults characterized by degeneration of articular cartilage of the joints in hands, spine, knees and hips. Tissue injury and pain are caused by conversion of arac

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  8. Development of Fiber-optic MR Imaging Catheters

    SBC: VIARES TECHNOLOGIES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Over 1,500,000 percutaneous coronary procedures are performed worldwide each year. Current diagnostic methods are based on detection of flow limiting atherosclerotic lesions by lumenal morphometry (x-ray angiography

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  9. A Dual Molecular/Tumor Targeting Therapy for PanCa

    SBC: SYNERGENE THERAPEUTICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Approximately 30,000 people in the United States are diagnosed each year with pancreatic cancer (PanCa). Over 90% of these will die of the disease making PanCa one of the most devastating human malignancies. The c

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  10. Cultural Competence in the Context of Type 2 Diabetes

    SBC: MEDICAL DIRECTIONS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): While the overall health of Americans has improved, ethnic minorities (particularly African Americans, Hispanics/Latinos, American Indians, Alaska Natives, Asians, and Pacific Islanders) continue to suffer from poorer

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government